These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 16454204)

  • 1. Correlation between in vitro release from topical delivery vehicles and microbicidal activity of triclosan.
    Swart HC; Du Preez JL; De Villiers MM; Lötter AP; Liebenberg W
    Pharmazie; 2006 Jan; 61(1):35-40. PubMed ID: 16454204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triclosan: a review of effectiveness and safety in health care settings.
    Jones RD; Jampani HB; Newman JL; Lee AS
    Am J Infect Control; 2000 Apr; 28(2):184-96. PubMed ID: 10760227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triclosan-loaded poloxamine micelles for enhanced topical antibacterial activity against biofilm.
    Chiappetta DA; Degrossi J; Teves S; D'Aquino M; Bregni C; Sosnik A
    Eur J Pharm Biopharm; 2008 Jun; 69(2):535-45. PubMed ID: 18194853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent antimicrobial action of triclosan-lysozyme complex against skin pathogens mediated through drug-targeted delivery mechanism.
    Hoq MI; Ibrahim HR
    Eur J Pharm Sci; 2011 Jan; 42(1-2):130-7. PubMed ID: 21078387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Triclosan, a topical dermatologic agent. In vitro- and in vivo studies on the effectiveness of a new preparation in the New German Formulary].
    Gloor M; Becker A; Wasik B; Kniehl E
    Hautarzt; 2002 Nov; 53(11):724-9. PubMed ID: 12402134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial effect of triclosan and triclosan with Gantrez on five common endodontic pathogens.
    Nudera WJ; Fayad MI; Johnson BR; Zhu M; Wenckus CS; Begole EA; Wu CD
    J Endod; 2007 Oct; 33(10):1239-42. PubMed ID: 17889698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of inclusion complexes of a cationic beta-cyclodextrin polymer with butylparaben or triclosan.
    Qian L; Guan Y; Xiao H
    Int J Pharm; 2008 Jun; 357(1-2):244-51. PubMed ID: 18294789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel, UV-curable coatings containing a tethered biocide: Synthesis, characterization, and antimicrobial activity.
    Chen Z; Chisholm BJ; Stafslien S; He J; Patel S
    J Biomed Mater Res A; 2010 Nov; 95(2):486-94. PubMed ID: 20665625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use.
    Jain J; Arora S; Rajwade JM; Omray P; Khandelwal S; Paknikar KM
    Mol Pharm; 2009; 6(5):1388-401. PubMed ID: 19473014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triclosan-tolerant bacteria: changes in susceptibility to antibiotics.
    Cottell A; Denyer SP; Hanlon GW; Ochs D; Maillard JY
    J Hosp Infect; 2009 May; 72(1):71-6. PubMed ID: 19246121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrophotometric determination of triclosan in personal care products.
    Lu H; Ma H; Tao G
    Spectrochim Acta A Mol Biomol Spectrosc; 2009 Sep; 73(5):854-7. PubMed ID: 19451017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial efficacy of triclosan-incorporated polymers.
    Kalyon BD; Olgun U
    Am J Infect Control; 2001 Apr; 29(2):124-5. PubMed ID: 11287882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triclosan-bacteria interactions: single or multiple target sites?
    Escalada MG; Russell AD; Maillard JY; Ochs D
    Lett Appl Microbiol; 2005; 41(6):476-81. PubMed ID: 16305673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effect of the combination triclosan with 2-phenylphenol against Pseudomonas aeruginosa and fungi.
    Tumah HN
    Saudi Med J; 2005 May; 26(5):723-7. PubMed ID: 15951857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial spectrum of Triclosan, a broad-spectrum antimicrobial agent for topical application.
    Vischer WA; Regös J
    Zentralbl Bakteriol Orig A; 1974 Mar; 226(3):376-89. PubMed ID: 4151802
    [No Abstract]   [Full Text] [Related]  

  • 16. Whither triclosan?
    Russell AD
    J Antimicrob Chemother; 2004 May; 53(5):693-5. PubMed ID: 15073159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of methylation on the antibacterial properties of triclosan in Pasteurella multocida and Pseudomonas aeruginosa variant strains.
    Clayborn AB; Toofan SN; Champlin FR
    J Hosp Infect; 2011 Feb; 77(2):129-33. PubMed ID: 21194793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the microcrystalline inclusion compounds of triclosan with β-cyclodextrin and its tris-O-methylated derivative.
    Ramos AI; Braga TM; Fernandes JA; Silva P; Ribeiro-Claro PJ; Almeida Paz FA; de Fátima Silva Lopes M; Braga SS
    J Pharm Biomed Anal; 2013 Jun; 80():34-43. PubMed ID: 23523864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of Triclosan in dentifrice formulations, with particular reference to a new 0.3% Triclosan calcium carbonate-based system.
    Brading MG; Cromwell VJ; Green AK; DeBrabander S; Beasley T; Marsh PD
    Int Dent J; 2004; 54(5 Suppl 1):291-8. PubMed ID: 15509079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis of triclosan activity.
    Levy CW; Roujeinikova A; Sedelnikova S; Baker PJ; Stuitje AR; Slabas AR; Rice DW; Rafferty JB
    Nature; 1999 Apr; 398(6726):383-4. PubMed ID: 10201369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.